Home » Topics » Regulatory » Patents

Patents
RSS

U.S. researchers patent antiparasitic compounds

Aug. 4, 2017

Boehringer Ingelheim discloses BTK and IL-6 production inhibitors

Aug. 3, 2017

RSV inhibitors identified by Enanta Pharmaceuticals

Aug. 3, 2017

Bristol-Myers Squibb presents ROCK2 inhibitors

Aug. 3, 2017

U.S. researchers patent EAAT2 activators

Aug. 3, 2017

Rockefeller University divulges FXIIa inhibitors

Aug. 2, 2017

Soluble guanylate cyclase activators presented by Bayer

Aug. 2, 2017

Teva presents laquinimod prodrugs for multiple sclerosis

Aug. 2, 2017

Arcus Biosciences divulges CD73 inhibitors

Aug. 2, 2017

Celgene identifies antiproliferative compounds for AML

Aug. 2, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...